Tyrosine-containing cyclophilin and related methods
AssigneeNew England Biolabs, Inc.
InventorsClotilde K. S. Carlow, Xiqiang Hong, Dong Ma
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of these cyclophilins, hereinafter referred to as ‘tyrosine-containing’ cyclophilins, in a method for identifying compounds capable of binding to and/or inhibiting the enzymatic activity of these proteins. Such compounds may be further screened for their ability to inhibit parasites which are not susceptible to the anti-parasitic effects of CsA.
Claims2
A method of screening for compounds capable of inhibiting peptidyl-prolyl cis-trans isomerase (PPIase) activity of a tyrosine-containing cyclophilin, or functional moiety thereof, the cyclophilin of the type identified in C. elegans, O. volvulus, B. malayi or D. immitis in which the conserved tryptophan at the CsA drug binding domain has been substituted by a tyrosine and where the cyclophilin is not inhibited by cyclosporin A, comprising:
- (a) contacting the tyrosine-containing cyclophilin with a test compound;
- (b) measuring an effect of the test compound on PPIase activity of the tyrosine-containing cyclophilin;
- and
- (c) determining whether the test compound is an inhibitor of the PPIase activity of the tyrosine-containing cyclophilin.
Dependencies are inferred from the claim text.